BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31757308)

  • 1. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
    Crombie JL; Armand P
    Surg Oncol Clin N Am; 2020 Jan; 29(1):115-125. PubMed ID: 31757308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
    Crombie JL; Armand P
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):575-585. PubMed ID: 31229155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Medicine in Pediatric Oncology.
    Vo KT; Parsons DW; Seibel NL
    Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
    Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
    Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Medicine.
    Khatri VP; Petrelli NJ
    Surg Oncol Clin N Am; 2020 Jan; 29(1):xv-xvi. PubMed ID: 31757318
    [No Abstract]   [Full Text] [Related]  

  • 6. Precision Medicine in the Treatment of Melanoma.
    Aderhold K; Wilson M; Berger AC; Levi S; Bennett J
    Surg Oncol Clin N Am; 2020 Jan; 29(1):1-13. PubMed ID: 31757306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine and Targeted Therapies in Breast Cancer.
    Greenwalt I; Zaza N; Das S; Li BD
    Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualizing Care: Management Beyond Medical Therapy.
    Cristoferi L; Nardi A; Invernizzi P; Mells G; Carbone M
    Surg Oncol Clin N Am; 2020 Jan; 29(1):87-103. PubMed ID: 31757316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Cancer: Genetics and the Role of Precision Medicine.
    Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
    Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Medicine in Lung Cancer Treatment.
    Shah DR; Masters GA
    Surg Oncol Clin N Am; 2020 Jan; 29(1):15-21. PubMed ID: 31757310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.
    Ennishi D; Hsi ED; Steidl C; Scott DW
    Cancer Discov; 2020 Sep; 10(9):1267-1281. PubMed ID: 32616477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Medicine in Gynecologic Cancer: Fact or Fiction?
    Corey L; Valente A; Wade K
    Surg Oncol Clin N Am; 2020 Jan; 29(1):105-113. PubMed ID: 31757307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine for Diffuse Large B-cell Lymphoma.
    Lim MS; Elenitoba-Johnson KS
    Clin Cancer Res; 2016 Jun; 22(12):2829-31. PubMed ID: 26988247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
    Wright GW; Huang DW; Phelan JD; Coulibaly ZA; Roulland S; Young RM; Wang JQ; Schmitz R; Morin RD; Tang J; Jiang A; Bagaev A; Plotnikova O; Kotlov N; Johnson CA; Wilson WH; Scott DW; Staudt LM
    Cancer Cell; 2020 Apr; 37(4):551-568.e14. PubMed ID: 32289277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.
    Iqbal J; Shen Y; Huang X; Liu Y; Wake L; Liu C; Deffenbacher K; Lachel CM; Wang C; Rohr J; Guo S; Smith LM; Wright G; Bhagavathi S; Dybkaer K; Fu K; Greiner TC; Vose JM; Jaffe E; Rimsza L; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Armitage JO; Weisenburger DD; Staudt LM; Gascoyne RD; McKeithan TW; Chan WC
    Blood; 2015 Feb; 125(7):1137-45. PubMed ID: 25498913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging prognostic factors in diffuse large B cell lymphoma.
    Gascoyne RD
    Curr Opin Oncol; 2004 Sep; 16(5):436-41. PubMed ID: 15314511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice.
    Weber T; Schmitz R
    Curr Oncol Rep; 2022 Jan; 24(1):13-21. PubMed ID: 35060000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular background of aggressive B cell lymphomas as a basis for targeted therapy.
    de Jong D; Balagué Ponz O
    J Pathol; 2011 Jan; 223(2):274-82. PubMed ID: 21125680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in extracutaneous lymphomas.
    Chott A; Raderer M
    Semin Cutan Med Surg; 2000 Jun; 19(2):149-56. PubMed ID: 10892718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.